| (+)-Xylariamide A |
|
|
|
|
|
|
|
|
|
|
|
|
| (E)-Dehydrodiconiferyl alcohol |
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-Sezolamide |
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-Sezolamide hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
| 2-Aminobenzenesulfonamide |
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| 2-Methoxybenzoic acid |
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| 2-Methoxybenzoic acid-13C6 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2-Methoxybenzoic acid-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
| 4-Chloro-3-sulfamoylbenzoic acid |
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| 4-Acetylphenylboronic acid |
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| hCAI/II/XII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| 4-Bromo-1H-indazole |
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| 5,6-Dihydro-2H-pyran-2-one |
|
|
|
|
|
|
|
|
|
|
|
|
| Acetazolamide sodium |
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| AChE/CA I-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| AChE/hCA I-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| AChE/hCA I/II-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Acipimox sodium |
|
|
|
|
|
|
|
|
|
|
|
|
| Actarit |
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| AHR-15010 |
|
|
|
|
|
|
|
|
|
|
|
|
| ALP/Carbonic anhydrase-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Aminozolamide |
|
|
|
|
|
|
|
|
|
|
|
|
| Anti-inflammatory agent 67 |
|
|
|
|
|
|
|
|
|
|
|
|
| Anti-inflammatory agent 68 |
|
|
|
|
|
|
|
|
|
|
|
|
| Antibacterial agent 167 |
|
|
|
|
|
|
|
|
|
|
|
|
| Anticancer agent 314 |
|
|
|
|
|
|
|
|
|
|
|
|
| Antitumor agent-163 |
|
|
|
|
|
|
|
|
|
|
|
|
| AV22-149 |
|
|
|
|
|
|
|
|
|
|
|
|
| BAY-79-4620 Antibody |
|
|
|
|
|
|
|
|
|
|
|
|
| BChE-IN-36 |
|
|
|
|
|
|
|
|
|
|
|
|
| BChE/hCA II-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Benzenesulphonamide |
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| CA inhibitor 2 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA IX-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA IX-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA IX-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA IX-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA IX/GPX4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA IX/VEGFR-2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA IX/VEGFR-2-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA Ⅱ-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA-II/Dkk1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA-II/TNAP-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA/MAO-B-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
98.34% |
| CA12 modulator-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CA9hu-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAI-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAI/II-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAI/II-IN-13 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAI0019 |
|
|
|
|
|
|
|
|
|
|
|
98.14% |
| CAII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAII-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAII-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAII-IN-13 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAII-IN-14 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAII-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAII-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAII-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAII/CAXII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAII/lX-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAII/VII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX Inhibitor S4 |
|
|
|
|
|
|
|
|
|
|
|
99.04% |
| CAIX-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX/CAXII-IN prodrug-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX/CAXII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX/CAXII-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX/CAXII-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX/CAXII-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX/CDK-2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX/XII-IN-16 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX/XII-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX/XII-IN-18 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAIX/XII/NAMPT-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase (isoenzyme) |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase activator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase II, Bovine |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase II, Human |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 10 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 11 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 12 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 13 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 14 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 15 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 16 |
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| Carbonic anhydrase inhibitor 17 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 18 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 19 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 2 |
|
|
|
|
|
|
|
|
|
|
|
98.40% |
| Carbonic anhydrase inhibitor 20 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 21 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 22 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 23 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 24 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 25 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 26 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 28 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 29 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 3 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 30 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 31 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 32 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 33 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 4 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 5 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 6 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 7 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase inhibitor 9 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase, E. coli |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase-IN-34 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase-IN-35 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase-IN-36 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase-IN-37 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase-IN-38 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase-IN-39 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase/AChE-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Carbonic anhydrase/AChE-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAXII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAXII-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| CAXII-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| CDK2-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
| CDK2-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
| Chloraminophenamide |
|
|
|
|
|
|
|
|
|
|
|
99.57% |
| Chlorzolamide |
|
|
|
|
|
|
|
|
|
|
|
|
| CL 5343 |
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Clofenamide |
|
|
|
|
|
|
|
|
|
|
|
|
| COX-2-IN-30 |
|
|
|
|
|
|
|
|
|
|
|
|
| Dealanylascamycin |
|
|
|
|
|
|
|
|
|
|
|
|
| Dichlorphenamide disodium |
|
|
|
|
|
|
|
|
|
|
|
|
| Diclofenamide-13C6 |
|
|
|
|
|
|
|
|
|
|
|
|
| Disulfamide |
|
|
|
|
|
|
|
|
|
|
|
|
| DOTA-XYIMSR-01 |
|
|
|
|
|
|
|
|
|
|
|
|
| DPI-4452 |
|
|
|
|
|
|
|
|
|
|
|
99.30% |
| DPP IV/hCA II-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| DSR-71167 |
|
|
|
|
|
|
|
|
|
|
|
|
| DTP348 |
|
|
|
|
|
|
|
|
|
|
|
|
| EGFR/CA-IX-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Elsulfavirine |
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Elsulfavirine sodium |
|
|
|
|
|
|
|
|
|
|
|
|
| EMAC10101d |
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| Enpp/Carbonic anhydrase-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
99.57% |
| Enpp/Carbonic anhydrase-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
98.48% |
| Ethoxzolamide-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
| FC11409B |
|
|
|
|
|
|
|
|
|
|
|
|
| FC14-584B |
|
|
|
|
|
|
|
|
|
|
|
|
| Furagin-13C3 |
|
|
|
|
|
|
|
|
|
|
|
|
| GV2-20 |
|
|
|
|
|
|
|
|
|
|
|
|
| GZ22-4 |
|
|
|
|
|
|
|
|
|
|
|
99.37% |
| hA2A/hCA XII modulator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hBChE-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA I-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA I-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA I-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA I-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA VB-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA XII-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA XII/II/IX-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA-I/hCA-II-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA-I/hCA-II-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA/VEGFR-2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA/VEGFR-2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA/VEGFR-2-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA/VEGFR-2-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA/VEGFR-2-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCA/Wnt/β-catenin-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| hCAI/II-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAI/II-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAI/II-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAI/II-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAI/II-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAI/II-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAI/II-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAI/II-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| hCAI/II-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| hCAI/II-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAII-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAII-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAII-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAII-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAII-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAII-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAII-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAII-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
99.41% |
| hCAII-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAII/IX-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAII/XII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| HCAIX-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-14 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-16 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-18 |
|
|
|
|
|
|
|
|
|
|
|
98.52% |
| hCAIX-IN-19 |
|
|
|
|
|
|
|
|
|
|
|
|
| HCAIX-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-20 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-21 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-22 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-23 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-24 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
98.32% |
| hCAIX-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/VII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-14 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAIX/XII-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAVII/IX-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| hCAXII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAXII-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAXII-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAXII-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAXII-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAXII-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAXII-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
| hCAXII-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-91 |
|
|
|
|
|
|
|
|
|
|
|
|
| Indan-5-sulphonamide |
|
|
|
|
|
|
|
|
|
|
|
|
| Indisulam |
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| IPM-N001 |
|
|
|
|
|
|
|
|
|
|
|
|
| KCN1 |
|
|
|
|
|
|
|
|
|
|
|
|
| L-645151 |
|
|
|
|
|
|
|
|
|
|
|
|
| L-650719 |
|
|
|
|
|
|
|
|
|
|
|
|
| L-662583 |
|
|
|
|
|
|
|
|
|
|
|
|
| L-693612 |
|
|
|
|
|
|
|
|
|
|
|
|
| L-693612 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
| Lasamide |
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Leptospermone |
|
|
|
|
|
|
|
|
|
|
|
98.46% |
| Mefruside |
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| Methyclothiazide |
|
|
|
|
|
|
|
|
|
|
|
99.61% |
| Mtb-IN-13 |
|
|
|
|
|
|
|
|
|
|
|
|
| N-Acetylsulfanilamide |
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| N-Desethyl Brinzolamide oxalate |
|
|
|
|
|
|
|
|
|
|
|
|
| NCX-278 |
|
|
|
|
|
|
|
|
|
|
|
|
| NSC 828467 |
|
|
|
|
|
|
|
|
|
|
|
|
| NYM074 |
|
|
|
|
|
|
|
|
|
|
|
|
| O-Desmethyl Brinzolamide hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5/CA-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| PDGFRA/CAIX/XII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
98.10% |
| Phenylsulfamide |
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Polmacoxib |
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| PROTAC hCAII degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Sezolamide |
|
|
|
|
|
|
|
|
|
|
|
|
| Sezolamide hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
| SH7s |
|
|
|
|
|
|
|
|
|
|
|
|
| STAT3/CAIX-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| TAS4464 |
|
|
|
|
|
|
|
|
|
|
|
98.69% |
| TAS4464 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
98.91% |
| Thioaspirine |
|
|
|
|
|
|
|
|
|
|
|
|
| TSPO/Carbonic Anhydrase Modulator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
| U-104 |
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| UK-390957 |
|
|
|
|
|
|
|
|
|
|
|
|
| VM4-037 |
|
|
|
|
|
|
|
|
|
|
|
|
| WES-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Xipamide |
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| α-Glucosidase-IN-63 |
|
|
|
|
|
|
|
|
|
|
|
|
| α-Glycosidase-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| α-Glycosidase-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| β-Glucuronidase/hCAII-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| β-Glucuronidase/hCAII-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| Trichlormethiazide |
|
|
|
|
|
|
|
|
|
|
|
98.54% |
| Trichlormethiazide sodium |
|
|
|
|
|
|
|
|
|
|
|
|
| Procodazole |
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| Acetazolamide-d3 |
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| Acetazolamide (Standard) |
|
|
|
|
|
|
|
|
|
|
|
99.57% |
| Acetazolamide-13C2,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
| Acetazolamide |
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Dichlorphenamide |
|
|
|
|
|
|
|
|
|
|
|
98.49% |
| Dimethylfraxetin |
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| Catechol diacetate |
|
|
|
|
|
|
|
|
|
|
|
|
| Zonisamide-15N,d4 |
|
|
|
|
|
|
|
|
|
|
|
|
| Ethoxzolamide |
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Perfluorohexane sulfonamide |
|
|
|
|
|
|
|
|
|
|
|
81.50% |
| Carzenide |
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| Girentuximab |
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Furagin |
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| Halazone |
|
|
|
|
|
|
|
|
|
|
|
75.0% |
| Zonisamide-d4 |
|
|
|
|
|
|
|
|
|
|
|
99.11% |
| Zonisamide-13C6 |
|
|
|
|
|
|
|
|
|
|
|
|
| Zonisamide |
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Zonisamide sodium |
|
|
|
|
|
|
|
|
|
|
|
|
| Quinethazone |
|
|
|
|
|
|
|
|
|
|
|
|
| Tioxolone |
|
|
|
|
|
|
|
|
|
|
|
98.24% |
| Dorzolamide |
|
|
|
|
|
|
|
|
|
|
|
|
| Dorzolamide-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
| Urea |
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| Urea-13C,15N |
|
|
|
|
|
|
|
|
|
|
|
|
| Brinzolamide |
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Brinzolamide-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
| Brinzolamide hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
| Brinzolamide-d5 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
| Topiramate |
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| Topiramate-13C |
|
|
|
|
|
|
|
|
|
|
|
|
| Topiramate-13C6 |
|
|
|
|
|
|
|
|
|
|
|
|
| Topiramate-13C6-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Topiramate D12 |
|
|
|
|
|
|
|
|
|
|
|
|
| Topiramate lithium |
|
|
|
|
|
|
|
|
|
|
|
|
| Vescalagin |
|
|
|
|
|
|
|
|
|
|
|
|
| Fluorometholone acetate |
|
|
|
|
|
|
|
|
|
|
|
98.54% |
| Chlorthalidone Impurity G |
|
|
|
|
|
|
|
|
|
|
|
|
| Dorzolamide hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| Dorzolamide hydrochloride (Standard) |
|
|
|
|
|
|
|
|
|
|
|
98% |
| Dorzolamide-d3 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
| Dorzolamide-d5(hydrochloride) |
|
|
|
|
|
|
|
|
|
|
|
|
| Punicalin |
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Carbonic anhydrase, Bovine erythrocytes |
|
|
|
|
|
|
|
|
|
|
|
|
| Sulclamide |
|
|
|
|
|
|
|
|
|
|
|
|
| Sulthiame-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
| Sultiame |
|
|
|
|
|
|
|
|
|
|
|
98.89% |
| Benzthiazide |
|
|
|
|
|
|
|
|
|
|
|
99.50% |
| Benzolamide |
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| Methazolamide-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
| Methazolamide |
|
|
|
|
|
|
|
|
|
|
|
99.41% |
| Acipimox |
|
|
|
|
|
|
|
|
|
|
|
99.58% |